Summit Securities Group’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-401
Closed -$2.07M 827
2021
Q1
$2.07M Sell
401
-71
-15% -$3.9K 0.23% 96
2020
Q4
$2.64M Sell
472
-94
-17% -$5.02K 0.22% 116
2020
Q3
$3.14M Sell
566
-94
-14% -$4.88K 0.33% 62
2020
Q2
$3M Buy
+660
New +$29.5K 0.37% 59

Other funds holding QGEN

Summit Securities Group's QGEN Position: Q1 2026 in Review

Summit Securities Group opened a new position in Qiagen (QGEN) in Q1 2026: 5,000 shares worth $200K. The stake represents 0.02% of the portfolio and ranks #227 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in QGEN as recently as Q2 2023.

Summit Securities Group first reported a position in QGEN in Q2 2020 and has held it in 7 quarters since. The position peaked at $7.48M in Q2 2023. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Summit Securities Group held 5,000 shares of Qiagen worth $200K as of Q1 2026.
  • Qiagen was a new Summit Securities Group position in Q1 2026.
  • Qiagen made up 0.02% of Summit Securities Group's portfolio in Q1 2026, its #227 holding.
  • Summit Securities Group first reported a position in Qiagen in Q2 2020 and has held it in 7 quarters since.
  • Summit Securities Group's Qiagen position peaked at $7.48M in Q2 2023.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.